A CWCI study finds that Calif WC claims from 2002 through 2011 that involved physician-dispensed repackaged drugs averaged 17 % higher medical benefit costs, 13% higher indemnity costs and 9% more lost-time days than similar claims without physician-dispensed repackaged drugs.